Fig. 1From: Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s diseaseStudy workflow. An overview of the study design and overall workflowBack to article page